Clinical trial
A Phase II, Open-label, Single Arm Study to Evaluate the Efficacy of Luspatercept in Erythropoiesis-stimulating Agent Naive Lower-risk MDS Patients With or Without Ring Sideroblasts Who do Not Require RBC Transfusions
NCT05384691 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Open-label, Single Arm Study to Evaluate the Efficacy of Luspatercept in Erythropoiesis-stimulating Agent Naive Lower-risk MDS Patients With or Without Ring Sideroblasts Who do Not Require RBC Transfusions
- Lead sponsor
- University of Leipzig
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 27, 2022
- Completion date
- July 31, 2027
- Enrollment
- 213 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.